Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on May 27, 2022 2:24am
RE:RE:Stock chart
I understand your frustration. And 300+ million shares is about 250 million shares more than I usually prefer to see when looking to invest. I blame management for most of that. Greedy bustards. What
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 27, 2022 1:46am
RE:Stock chart
Retailers who have been in for a long time are holding because they have no choice due to lack of bids. Retailers who bought higher are holding because they haven't made money. New retailers and
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on May 26, 2022 11:12pm
RE:Stock chart
Sorry. Chart won't work. Try this link to Stockcharts and page down to the weekly chart. https://stockcharts.com/freecharts/gallery.html?SVA.V
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Post by
Stockfshr
on May 26, 2022 11:09pm
Stock chart
When you look at a weekly chart of SVA like the one below, you can see that we have been in a fairly narrow trading range (ignoring the odd anomaly) since about March of 2021. That compares pretty
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on May 26, 2022 5:49pm
RE:RE:RE:BioHub
Conformal coating - Sernova "entered into an exclusive, worldwide licence with the University of Miami at Coral Gables, Florida, for the commercial rights to novel conformal coating immune
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 26, 2022 3:56pm
RE:RE:BioHub
Yeah, I've seen that. Weird part is that Camillo Ricordi and Tomei were the ones who came up with the Conformal Coating. If they are working on something similar on their own, why would they
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on May 26, 2022 3:38pm
RE:BioHub
See link below for a November 2021 article that indicates that DRIs "mini-pancreas" phase I/II trial is ongoing and that DRI announced its first successful results in 2016. Does make one
...more
(24)
•••
steadfast
X
View Profile
View Bullboard History
Comment by
steadfast
on May 26, 2022 3:08pm
RE:RE:RE:RE:Another 2 cent close today helps to $1.60 close Fri
Bio-Teck, I agree with you. If I am going to encourage the I.R. guys to look at Fibonacci Chart, which I sent to Philip to forward to I.R., then I should buy shares to ensure stock closes over
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on May 26, 2022 2:20pm
BioHub
Anyone have any more info on DRI's BioHub? It appears they were able to get someone off insulin way back in 2015. From what I see, they could have a device that does what the Cell Pouch does.
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on May 26, 2022 2:12pm
Procyon
This company Procyon was able to get a deal with Novo Nordisk with their version of the Cell Pouch which is clearly much inferior 2 years ago. Makes you wonder why Sernova took so long to get
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 25, 2022 3:33pm
RE:Another 2 cent close today helps to $1.60 close Fri
steadfast..you watch too much Harry Potter. Almost all predictive models and indicators rely on a stock trading with a statistically significant volume with a large number of traders on a regular
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 25, 2022 12:20pm
RE:RE:RE:Another 2 cent close today helps to $1.60 close Fri
Thanks for the history lesson, I am fully aware who Leo is. If fact Leo may know our IR team as they are also from the middle ages. Keep encouraging them and maybe one day they'll get something
...more
(24)
•••
steadfast
X
View Profile
View Bullboard History
Comment by
steadfast
on May 25, 2022 11:36am
RE:RE:Another 2 cent close today helps to $1.60 close Fri
Leonardo Fibonacci was considered "the most talented Westerner Mathemetcian of the Middle Ages". He completed his work at age of 32 in 1202. It has stood the test of time for 820
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 25, 2022 9:32am
RE:Another 2 cent close today helps to $1.60 close Fri
Steadfast....you're starting to sound like a crazy person with all this Fibonacci stuff...
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >